BNP Paribas Call 11000 LDSVF 20.0.../ DE000PN8TM68 /
20/06/2024 10:12:07 | Var.+0.060 | Denaro11:20:34 | Lettera11:20:34 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.350EUR | +20.69% | 0.320 Quantità in denaro: 16,500 |
0.340 Quantità in lettera: 16,500 |
Lindt & Sprungli AG | 11,000.00 - | 20/09/2024 | Call |
GlobeNewswire
13:05
CAE INVESTOR REMINDER: CAE, Inc. (NYSE:CAE) Investors that Lost Money on Their Investment When the C...
GlobeNewswire
13:00
Emergent BioSolutions Announces Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals ...
GlobeNewswire
13:00
atai Life Sciences Announces Update on Beckley Psytech’s Phase 1/2a Trial of ELE-101 (IV Psilocin) f...
GlobeNewswire
13:00
Dragonfly Energy Unveils Next-Generation of Power Charging Solutions Under the Company’s Wakespeed® ...
GlobeNewswire
13:00
Spur Therapeutics to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Confer...
GlobeNewswire
13:00
Verano Files Court Response Seeking Full Trial and Rejecting Goodness Growth’s Damages Claim
GlobeNewswire
13:00
Emergency Services Inc. Partners with Augmedix to Introduce Generative AI Solution That Relieves Cli...
GlobeNewswire
13:00
Village Farms International Congratulates Netherlands on Cannabis Program Milestone
GlobeNewswire
13:00
United Hydrogen Group Inc., a Comprehensive Hydrogen Solution Company in China, Announces Execution ...
GlobeNewswire
13:00
Tessera Therapeutics Presents Non-Human Primate (NHP) Data in Alpha-1 Antitrypsin Deficiency (AATD) ...
GlobeNewswire
13:00
Lantronix to Participate in ROTH 10ᵗʰ Annual London Conference Held June 26–27, 2024
GlobeNewswire
13:00
Trevena Announces Preclinical TRV045 Data Providing Insight Into Novel Mechanism of Analgesic Effect...